We have also identified tm6sf2, which is associated with both the risk and the severity of nonalcoholic fatty liver disease [29] as well as with the regulation of inflammatory responses in atherosclerotic lesions [30]. Here, TM6SF2 is linked to metabolic dysfunction-associated steatotic liver disease.